These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38690037)

  • 1. Construction of a predictive model for acute liver failure after hepatectomy based on neutrophil-to-lymphocyte ratio and albumin-bilirubin score.
    Li XP; Bao ZT; Wang L; Zhang CY; Yang W
    World J Gastrointest Surg; 2024 Apr; 16(4):1087-1096. PubMed ID: 38690037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy.
    Luo H; Huang C; Meng M; Zhang M; Li Z; Huang J
    BMC Gastroenterol; 2023 May; 23(1):162. PubMed ID: 37208618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review.
    Bannaga A; Arasaradnam RP
    World J Gastroenterol; 2020 Sep; 26(33):5022-5049. PubMed ID: 32952347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.
    Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C
    J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel online calculator based on noninvasive markers (ALBI and APRI) for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma.
    Shi JY; Sun LY; Quan B; Xing H; Li C; Liang L; Pawlik TM; Zhou YH; Wang H; Gu WM; Chen TH; Lau WY; Shen F; Wang NY; Yang T
    Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101534. PubMed ID: 33067168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between Child-Pugh score and Albumin-Bilirubin grade in the prognosis of patients with HCC after liver resection using time-dependent ROC.
    Zhao S; Wang M; Yang Z; Tan K; Zheng D; Du X; Liu L
    Ann Transl Med; 2020 Apr; 8(8):539. PubMed ID: 32411762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
    Luo H; Li C; Chen L
    Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prediction model of mid-term fatality risk after radical resection in patients with hepatocellular carcinoma based on ALBI-grade].
    Wang X; Zhang Z; Wu Z; Sun Y; Zhang Y; Gong M; Ji F
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2020 May; 49(3):375-382. PubMed ID: 32762166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining albumin-bilirubin score with future liver remnant predicts post-hepatectomy liver failure in HBV-associated HCC patients.
    Zou H; Wen Y; Yuan K; Miao XY; Xiong L; Liu KJ
    Liver Int; 2018 Mar; 38(3):494-502. PubMed ID: 28685924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection.
    Qiu ZC; Li C; Zhang Y; Xie F; Yu Y; Leng SS; Chen TH; Wen TF
    Langenbecks Arch Surg; 2023 Jun; 408(1):250. PubMed ID: 37382724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Inflammation-Based Prognostic Score: The Fibrinogen/Albumin Ratio Predicts Prognoses of Patients after Curative Resection for Hepatocellular Carcinoma.
    Xu Q; Yan Y; Gu S; Mao K; Zhang J; Huang P; Zhou Z; Chen Z; Zheng S; Liang J; Lin Z; Wang J; Yan J; Xiao Z
    J Immunol Res; 2018; 2018():4925498. PubMed ID: 30027102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Albumin-bilirubin Score as a Predictor of Post-hepatectomy Liver Failure in Patients with Hepatocellular Carcinoma.
    Park HJ; Seo KI; Kim SJ; Lee SU; Yun BC; Han BH; Shin DH; Choi YI; Moon HH
    Korean J Gastroenterol; 2021 Mar; 77(3):115-122. PubMed ID: 33658474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
    Yang C; Wu X; Liu J; Wang H; Jiang Y; Wei Z; Cai Q
    J Hepatocell Carcinoma; 2023; 10():43-55. PubMed ID: 36660412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel online calculator based on albumin-bilirubin and aspartate transaminase-to-platelet ratio index for predicting postoperative morbidity following hepatectomy for hepatocellular carcinoma.
    Sun LY; Zhu H; Diao YK; Xing H; Liang L; Li J; Zhou YH; Gu WM; Chen TH; Zeng YY; Pawlik TM; Lau WY; Li C; Shen F; Zhang CW; Yang T
    Ann Transl Med; 2020 Dec; 8(23):1591. PubMed ID: 33437790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative albumin-bilirubin grade plus platelet-to-lymphocyte ratio predict the outcomes of patients with BCLC stage A hepatocellular carcinoma after liver resection.
    Li C; Zhang XY; Peng W; Wen TF; Yan LN; Li B; Yang JY; Wang WT; Xu MQ; Chen LP
    Medicine (Baltimore); 2018 Jul; 97(29):e11599. PubMed ID: 30024565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals.
    Casadei Gardini A; Foschi FG; Conti F; Petracci E; Vukotic R; Marisi G; Buonfiglioli F; Vitale G; Ravaioli F; Gitto S; Verucchi G; Lenzi M; Bolondi L; Mazzella G; Brillanti S; Andreone P;
    Dig Liver Dis; 2019 May; 51(5):681-688. PubMed ID: 30327251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Child-Pugh grade
    Huang F; Gao J
    World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization.
    Ananchuensook P; Sriphoosanaphan S; Suksawatamnauy S; Siripon N; Pinjaroen N; Geratikornsupuk N; Kerr SJ; Thanapirom K; Komolmit P
    BMC Gastroenterol; 2022 Jun; 22(1):295. PubMed ID: 35701739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALBI score combined with FIB-4 index to predict post-hepatectomy liver failure in patients with hepatocellular carcinoma.
    Tian YB; Niu H; Xu F; Shang-Guan PW; Song WW
    Sci Rep; 2024 Apr; 14(1):8034. PubMed ID: 38580647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Of ALBI And APRI To Predict Post-Hepatectomy Liver Failure After Liver Resection For HBV-Related HCC Patients.
    Mai RY; Wang YY; Bai T; Chen J; Xiang BD; Wu GB; Wu FX; Li LQ; Ye JZ
    Cancer Manag Res; 2019; 11():8799-8806. PubMed ID: 31632139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.